Count | |
| 8 | |
| 11 | |
| 22 | |
| 9 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Interferon Alfa-2b/*adverse effects/pharmacology/therapeutic use | 1 |
| 2 | |
| 20 | |
| 1 | |
| 40 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 14 | |
| 7 | |
| 1 | |
| 1 | |
| 1 | |
| 7 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 6 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 6 | |
| 3 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 59 | |
| 135 | |
| 45 | |
| 18 | |
| 46 | |
| 95 | |
| 436 | |
| 49 | |
| 595 | |
| 20 | |
| 1 | |
| 4 | |
| 2 | |
| 1 | |
| 5 | |
| 8 | |
| 32 | |
| 1 | |
| 2 | |
| 3 | |
| 3 | |
| 7 | |
| 9 | |
| 1 | |
| 1 | |
| 7 | |
| 2 | |
| 6 | |
| 8 | |
| 1 | |
| 4 | |
| 1 | |
| 3 | |
| 133 | |
| 3 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 4 | |
| 2 | |
| 3 | |
| 2 | |
| 49 | |
| 1 | |
| 2 | |
| 3 | |
| 1 | |
| 14 | |
| 5 | |